Showing results (2371-2380 of 2,473) with videos related to
Sort By:
Pageof 248
BMJ Open|July 5, 2022
Protocol for a process evaluation: face-to-face physiotherapy compared with a supported home exercise programme for the management of musculoskeletal conditions: the REFORM trialHannah G Withers, Hueiming Liu, Joanne V Glinsky, et al.Science Advances|February 4, 2026
In vivo functional profiling and structural characterization of the human GLP1R A316T variantLiliane El Eid, Yusman Manchanda, Gregory Austin, et al.Pediatrics|July 26, 2006
Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategiesNancy Roizen, Kristen Kasza, Theodore Karrison, et al.Health Technology Assessment (Winchester, England)|June 15, 2017
Seal or Varnish? A randomised controlled trial to determine the relative cost and effectiveness of pit and fissure sealant and fluoride varnish in preventing dental decayIvor Gordon Chestnutt, Simon Hutchings, Rebecca Playle, et al.Nature Nanotechnology|September 8, 2014
Twist-controlled resonant tunnelling in graphene/boron nitride/graphene heterostructuresA Mishchenko, J S Tu, Y Cao, et al.Nature Cell Biology|August 18, 2015
mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotypeNicolás Herranz, Suchira Gallage, Massimiliano Mellone, et al.Vaccines|September 23, 2022
Factors Associated with Vaccination Intention against the COVID-19 Pandemic: A Global Population-Based StudyJunjie Huang, Sze Chai Chan, Samantha Ko, et al.Respiratory Medicine|February 17, 2025
Optimising outcomes for adults with cystic fibrosis taking CFTR modulators by individualising care: Personalised data linkage to understand treatment optimisation (PLUTO), a novel clinical frameworkRobert D Sandler, Alan Anderson, Tracy Barnett, et al.Nature Communications|January 24, 2024
Rapid functional impairment of natural killer cells following tumor entry limits anti-tumor immunityIsaac Dean, Colin Y C Lee, Zewen K Tuong, et al.Antimicrobial Agents and Chemotherapy|August 17, 2002
N-alkyl urea hydroxamic acids as a new class of peptide deformylase inhibitors with antibacterial activityCorinne J Hackbarth, Dawn Z Chen, Jason G Lewis, et al.Pageof 248